The Rotherham NHS Foundation Trust Clinical Research
  • Home
  • RFT R&D Department
    • About RFT R&D
    • Who's who
    • Resources
    • NIHR support
    • Library Support
    • Contact
    • Red4Research 2024
  • Why research matters
    • Clinical research in the NHS
    • Why research is important
    • Evidence
    • Key messages
  • Departments
    • All Departments
    • Anaesthesia, Perioperative Medicine & Pain Management
    • Breathing Space
    • Cancer
    • Cardiovascular Medicine
    • Critical Care
    • Dermatology
    • Ear, Nose & Throat Surgery
    • Emergency Medicine
    • Gastroenterology & Colorectal
    • Haematology
    • Infectious Diseases
    • Mental Health
    • Neurology
    • Nutrition & Dietetics
    • Obstetrics, Gynaecology & Reproductive Health
    • Ophthalmology
    • Oral Medicine
    • Orthopaedics
    • Paediatrics
    • Physiotherapy
    • Public Health
    • Respiratory Medicine
    • Rheumatology
    • Sexual Health
    • Speech & Language
    • Surgical
    • Urology
  • Your role in research
    • Clinical staff
    • Other patient contact roles
    • Communications
    • Clinical management
    • Corporate services
    • Trust executives & senior management
  • Home
  • RFT R&D Department
    • About RFT R&D
    • Who's who
    • Resources
    • NIHR support
    • Library Support
    • Contact
    • Red4Research 2024
  • Why research matters
    • Clinical research in the NHS
    • Why research is important
    • Evidence
    • Key messages
  • Departments
    • All Departments
    • Anaesthesia, Perioperative Medicine & Pain Management
    • Breathing Space
    • Cancer
    • Cardiovascular Medicine
    • Critical Care
    • Dermatology
    • Ear, Nose & Throat Surgery
    • Emergency Medicine
    • Gastroenterology & Colorectal
    • Haematology
    • Infectious Diseases
    • Mental Health
    • Neurology
    • Nutrition & Dietetics
    • Obstetrics, Gynaecology & Reproductive Health
    • Ophthalmology
    • Oral Medicine
    • Orthopaedics
    • Paediatrics
    • Physiotherapy
    • Public Health
    • Respiratory Medicine
    • Rheumatology
    • Sexual Health
    • Speech & Language
    • Surgical
    • Urology
  • Your role in research
    • Clinical staff
    • Other patient contact roles
    • Communications
    • Clinical management
    • Corporate services
    • Trust executives & senior management

haematology


NIHR Portfolio Studies - open to recruitment:

Picture
    

RADAR (UK-MRA Myeloma XV)
Principal Investigator: Dr Arun Alfred
Sponsor: University of Leeds
Comparing treatment escalation and de-escalation strategies in newly diagnosed patients with multiple myeloma. 
Picture
  
    

SECURE
Principal Investigator: Dr Arun Alfred
Co-investigators: Dr Kathryn Goddard, Dr James Taylor, Dr Joe Joseph
Sponsor: Oxford University Hospitals NHS Foundation Trust
This study aims to find out more about the role of family history and demographic factors in the development of MGUS (monoclonal gammopathy of undetermined significance). it will also find out more about the psychological impact of an MGUS diagnosis and individual quality of life. 
Picture
​PROPEL
Principal Investigator: Dr James Taylor
Sponsor: University of Warwickshire & University Hospitals Coventry and Warwickshire
This trial aims to establish the clinical impact and cost-effectiveness of best practice usual care compared to a multiphasic multimodal personalised prehabilitation care package on fatigue, emotional wellbeing and quality of life in patients in remission following induction chemotherapy. 

nihr portfolio studies - in follow up:

Picture
FLAIR: A trial of ibrutinib with rituximab for chronic lymphocytic leukaemia
Principal Investigator: Dr Kathryn Goddard
Sponsor: University of Leeds
This trial is comparing ibrutinib alongside rituximab with fludarabine, cyclophosphamide, rituximab and venetoclax for chronic lymphocytic leukaemia. This trial is for people who haven’t yet had treatment for their chronic lymphocytic leukaemia (CLL).

Picture
STATIC: Intermittent vs Continuous treatment strategies in CLL
Principal Investigator: Dr Kathryn Goddard
Sponsor: University of Leeds
The primary aim of this study is to assess whether patients with Chronic Lymphocytic Leukaemia (CLL) on long-term treatment with BTK inhibitor (including ibrutinib) have similar disease control with an intermittent treatment strategy compared with standard continuous treatment. ​
Image credit: "A test tube tray containing a number of purple tipped vacutainer tubes. Original image sourced from US Government department: Public Health Image Library, Centers for Disease Control and Prevention. https://www.rawpixel.com/image/2288494/free-photo-image-laboratory-medical-test 
Contact us
Site Map
Site A-Z
​
Accessibility Statement
Accessibility Roadmap
Privacy Policy
RFT R&D Department
Research in Rotherham

Get involved in research
Picture
All content © 2023 The Rotherham NHS Foundation Trust unless otherwise stated. ​